USPTO serial 99061738
Serial No. 99061738
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 28, 2025
- Examiner
- MICHELI, ANGELA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 99061738?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Warrington, PA, US
Warrington, PA, US
Warrington, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leah N. George
Leah N. George Caesar Rivise, PC7 Penn Center, 12th Floor1635 Market StreetPhiladelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations for scientific purposes; Chemical and biochemical products in the nature of chemical preparations for scientific use and for research, other than for medical or veterinary use; Chemical and biochemical products in the nature of chemical preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles, other than for medical or veterinary use; Chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; Chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles; Chemical preparations for scientific purposes; Chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; Chemical reagents for non-medical purposes | ACTIVE | Apr 1, 2024 |
| 005 | Chemicals and biochemicals for medical and clinical use, namely, chemical and biochemical preparations for discovery and development of cell and gene therapy for treating genetic diseases; Chemicals and biochemicals for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles for the discovery and development of cell and gene therapies for treating genetic diseases; Chemical preparations for medical use for research and for genetic diagnostics, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; Diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles, for use in disease testing; Pharmaceutical products for the treatment of genetic diseases; Medicines for the treatment of genetic diseases | ACTIVE | Apr 1, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 7, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 28, 2025 | NWAP | NEW APPLICATION ENTERED | — |